Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

Tegsedi for the Treatment of Polyneuropathy of hATTR Amyloidosis

Tegsedi™ binds to TTR messenger RNA to reduce the production of TTR. Image courtesy of U.S. National Library of Medicine, National Institutes of Health, Health & Human Services.

  • Tegsedi
  • Tegsedi
  • Tegsedi

Go Top